In a report released today, Charles Rhyee from TD Cowen reiterated a Buy rating on GoodRx Holdings (GDRX – Research Report), with a price ...

Santa Monica-based prescription medication discount provider GoodRx Holdings Inc. wants its customers and other medication ...

GoodRx CEO Wendy Barnes outlined the company's priorities at the 2025 JP Morgan Healthcare Conference in San Francisco.

The development of drug treatments for obesity in adults has raised questions about treatment of childhood obesity. Image credit: PeopleImages.com – Yuri A The prevalence of obesity has increased ...

GoodRx CEO Wendy Barnes discusses how telepharmacy firms navigate pricing and the outlook for obesity drugs with Katherine Greifeld at the JPMorgan Health-Care Conference in San Francisco.

GoodRx is the number one healthcare platform ... It's a huge opportunity, because there are thousands and thousands and, for some drugs, hundreds of thousands of consumers that are coming every ...

Amid declining retail pharmacy traffic, GoodRx has shifted to crafting relationships directly with pharmaceutical manufacturers, who desire to directly advertise their drugs on GoodRx's platform.

Of the hundreds of drugs that entered the U.S. market in 2024, GoodRx has named 19 of them as the most notable. Note: The chronological list does not include December approvals. 1. Dupixent ...

In a disclaimer, GoodRx noted that the list was created by prioritizing "first-in-class medications and vaccines that are expected to have a significant impact on human health." "This was defined ...